J.B. Chemicals & Pharmaceuticals Company Profile - Aug 19, 2011 by WrightReports

VIEWS: 80 PAGES: 10

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   J.B. Chemicals & Pharmaceuticals Ltd
                                                                                        440 Wheelers Farms Road
                                                                                        Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Indian Rupees

                                Wright Quality Rating:DAB13                                 Key Data

   J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is an India-based pharmaceutical          Ticker:
   company that manufactures and markets a range of pharmaceutical formulations,            506943
   bulk drugs, intermediates, radio-diagnostics, herbal remedies and active
   pharmaceutical ingredients (APIs). JBCPL exports its products to countries               2011 Sales:
   worldwide, including South Africa, other South African countries and South-East
                                                                                            8,475,807,000
   Asian countries. The Company's brands include Doktor Mom, Metrogyl, Rantac,
   Nicardia Retard, Dicloran and Cilacar. Its API's products include Atenolol USP,
   Ciprofloxacin Hydrochloride USP, Cilnidipine, Diclofenac Acid, Diclofenac Diethylamine   Major Industry:
   BP, Gadopentatic Acid and Diclofenac Sodium BP. JBCPL's formulation products             Drugs, Cosmetics & Health
   include Detrax, Vermorex, Ofloxacin, Metronidazole, Metrogyl, Zithrocin and Cefjoy.      Care
                       Stock Chart                                   Officers
                                                              Chairman & Managing           Sub Industry:
                                                                    Director                Ethical Drug Manufacturers
                                                                Jyotindra B. Mody
                                                                                            Country:
                                                              President & Executive         India
                                                                     Director
                                                                 Pranabh D. Mody            Currency:
                                                                                            Indian Rupees
                                                                Secretary & Chief
                                                               Compliance Officer
                                                                                            Fiscal Year Ends:
                                                                 Mayur C. Mehta
                                                                                            March

                                                                                            Employees
                                                                                            2,708

                                                                                            Exchanges:
                                                                                            BOM

                                                                                            Share Type:
           Stock Price (8/12/2011): 148.10                                                  Ordinary
              Recent stock performance
                  1 Week       9.2%
                                    
								
To top